United States
20
2014-07-10
The entities that hold a legal rights for patent applications filed by inventor Hoffmann-La Roche Inc.:
Hoffmann-La Roche Inc. from , US has applied for patents for these inventions. The list has both pending applications and granted patents:
METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY
#2 | 2014-03-20COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF
#3 | 2014-03-13USE OF PEGYLATED IGF-1 VARIANTS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS
#4 | 2014-03-06Antibodies against human angiopoietin 2
#5 | 2014-02-13Serpin-finger fusion polypeptide
#6 | 2014-02-06ANTI-HUMAN IgG1 ANTIBODY
#7 | 2014-01-30SPECTROSCOPIC FINGER-PRINTING OF RAW MATERIALS
#8 | 2014-01-16METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY
#9 | 2014-01-16METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY
#10 | 2014-01-02COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH AN ANTI-BCL-2 ACTIVE AGENT
#11 | 2013-12-19Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
#12 | 2013-12-19Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
#13 | 2013-08-29Substituted naphthylacetic acids
#14 | 2013-08-22PREDICTIVE MARKER FOR EGFR INHIBITOR TREATMENT
#15 | 2013-08-22PREDICTIVE MARKER FOR EGFR INHIBITOR TREATMENT
#16 | 2013-08-22Pyrrolidine derivatives
#17 | 2013-08-22CONJUGATES OF INSULIN-LIKE GROWTH FACTOR-1 AND POLY(ETHYLENE GLYCOL)
#18 | 2013-08-15Predictive marker for EGFR inhibitor treatment
#19 | 2013-08-15Azetidine derivatives
#20 | 2013-08-15FORMULATION COMPRISING AN ANTIBODY AGAINST P-SELECTIN
388538 ⎘